Literature DB >> 15205321

Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles.

Kyle A Furge1, Kerry A Lucas, Masayuki Takahashi, Jun Sugimura, Eric J Kort, Hiro-omi Kanayama, Susumu Kagawa, Philip Hoekstra, John Curry, Ximing J Yang, Bin T Teh.   

Abstract

Renal cell carcinoma (RCC) is a heterogeneous disease that includes several histologically distinct subtypes. The most common RCC subtypes are clear cell, papillary, and chromophobe, and recent gene expression profiling studies suggest that classification of RCC based on transcriptional signatures could be beneficial. Traditionally, however, patterns of chromosomal alterations have been used to assist in the molecular classification of RCC. The purpose of this study was to determine whether it was possible to develop a classification model for the three major RCC subtypes that utilizes gene expression profiles as the bases for both molecular genetic and cytogenetic classification. Gene expression profiles were first used to build an expression-based RCC classifier. The RCC gene expression profiles were then examined for the presence of regional gene expression biases. Regional expression biases are genetic intervals that contain a disproportionate number of genes that are coordinately up- or down-regulated. The presence of a regional gene expression bias often indicates the presence of a chromosomal abnormality. In this study, we demonstrate an expression-based classifier can distinguish between the three most common RCC subtypes in 99% of cases (n = 73). We also demonstrate that detection of regional expression biases accurately identifies cytogenetic features common to RCC. Additionally, the in silico-derived cytogenetic profiles could be used to classify 81% of cases. Taken together, these data demonstrate that it is possible to construct a robust classification model for RCC using both transcriptional and cytogenetic features derived from a gene expression profile.

Entities:  

Mesh:

Year:  2004        PMID: 15205321     DOI: 10.1158/0008-5472.CAN-04-0534

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  33 in total

Review 1.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

2.  Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.

Authors:  A Rose Brannon; Anupama Reddy; Michael Seiler; Alexandra Arreola; Dominic T Moore; Raj S Pruthi; Eric M Wallen; Matthew E Nielsen; Huiqing Liu; Katherine L Nathanson; Börje Ljungberg; Hongjuan Zhao; James D Brooks; Shridar Ganesan; Gyan Bhanot; W Kimryn Rathmell
Journal:  Genes Cancer       Date:  2010-02-01

3.  [Papillary renal cell carcinoma and tumor biology. A multicenter project with "tissue microarray" (TMA)].

Authors:  E Herrmann; C Wülfing; A Hartmann
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

4.  VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.

Authors:  Andrew J Evans; Ryan C Russell; Olga Roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Y Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S Irwin; Bin T Teh; Michael A S Jewett; Michael Ohh
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 5.  Perspectives in drug development for metastatic renal cell cancer.

Authors:  Bristi Basu; Tim Eisen
Journal:  Target Oncol       Date:  2010-08-06       Impact factor: 4.493

6.  Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Authors:  Min-Han Tan; Chin Fong Wong; Hwei Ling Tan; Ximing J Yang; Jonathon Ditlev; Daisuke Matsuda; Sok Kean Khoo; Jun Sugimura; Tomoaki Fujioka; Kyle A Furge; Eric Kort; Sophie Giraud; Sophie Ferlicot; Philippe Vielh; Delphine Amsellem-Ouazana; Bernard Debré; Thierry Flam; Nicolas Thiounn; Marc Zerbib; Gérard Benoît; Stéphane Droupy; Vincent Molinié; Annick Vieillefond; Puay Hoon Tan; Stéphane Richard; Bin Tean Teh
Journal:  BMC Cancer       Date:  2010-05-12       Impact factor: 4.430

Review 7.  The changing face of renal cell carcinoma pathology.

Authors:  Hakan Aydin; Ming Zhou
Journal:  Curr Oncol Rep       Date:  2008-05       Impact factor: 5.075

Review 8.  Treatment selection for patients with metastatic renal cell carcinoma.

Authors:  Michael B Atkins; Toni K Choueiri; Daniel Cho; Meredith Regan; Sabina Signoretti
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

9.  High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.

Authors:  Maria V Yusenko; Roland P Kuiper; Tamas Boethe; Börje Ljungberg; Ad Geurts van Kessel; Gyula Kovacs
Journal:  BMC Cancer       Date:  2009-05-18       Impact factor: 4.430

10.  Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours.

Authors:  Maria V Yusenko; Dmitry Zubakov; Gyula Kovacs
Journal:  Int J Biol Sci       Date:  2009-07-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.